Skip to main content

Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.

Packham MA, Bryant NL, Guccione MA, Kinlough-Rathbone RL, Mustard JF

Publication: Thromb Haemost (1989) • Vol 62 • Page 968-76PMID: 2512683View on PubMed

Purpose

The purpose of this paper was to determine the effects of calcium (Ca) concentration in platelet suspension medium, anticoagulant used for platelet rich plasma (PRP), and type of agonist used on aggregation, formation of Thromboxane B2 (TXB2), and release of serotonin.

Conclusion

The anticoagulant used to obtain PRP and the amount of Ca added to platelets resuspended in modified Tyrode-albumin solution have significant agonist-dependent effects on platelet aggregation, serotonin release, and TXB2 formation. Further, aspirin treatment, indomethacin treatment, the addition of arginine-glycine-asparagine-serine peptide (RGDS), or not stirring the specimen after the addition of the agonist can have inhibitory effects on platelet aggregation, serotonin release, and TXB2 formation.

Studies (1)

Purpose

The purpose of this study was to determine the effects of Ca concentration in platelet suspension medium, anticoagulant used for PRP, and type of agonist used on aggregation, formation of TXB2, and release of serotonin.

Summary of Findings

When D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone (PPACK) was used as an anticoagulant, the secondary phase of adenosine diphosphate (ADP)-induced aggregation was inhibited, serotonin was not released, and TXB2 was not formed, however, citrated PRP or PRP anticoagulated with both PPACK and citrate exhibited primary and secondary ADP-induced aggregation, TXB2 formation, and release of serotonin. The addition of Ca to modified Tyrode-albumin solution had an inhibitory effect on ADP-induced aggregation, serotonin release, and TXB2 formation among resuspended platelets. Aspirin blocked the second phase of ADP-induced aggregation, TXB2 formation, and serotonin release for platelets resuspended with no added Ca and for PRP anticoagulated with citrate or citrate and PPACK. The addition of RGDS to the medium or not stirring after ADP addition each decreased serotonin release and TXB2 formation. The addition of RGDS also blocked aggregation. Thrombin-induced aggregation and serotonin release were maximal in resuspended platelets with 0-2 mM added Ca, while TXB2 formation was maximal in platelet suspensions with no added Ca. Aspirin and indomethacin treatment had no effects on thrombin-induced platelet aggregation when 0-2 mM of Ca was added to the medium but a strong inhibition when 5 mM of Ca was added to the medium, and these treatments also reduced serotonin release. The secondary phase of aggregation did not occur during platelet activating factor (PAF)-induced aggregation when PPACK was used as the sole anticoagulant, and aspirin treatment inhibited the secondary phase of aggregation among PRP anticoagulated with citrate or PPACK and citrate. Collagen-induced aggregation, serotonin release, and TXB2 formation were greatest when no Ca was added to the medium. Arachidonic acid-induced aggregation and serotonin release were inhibited when 5 mM of Ca was added to the platelet suspension medium, and TXB2 formation did not occur when this agonist was used.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
  • Platforms

    Cell count/volumeHematology/ auto analyzer
    Small moleculeRadioimmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Citrate
    PPACK
    Biospecimen Aliquots and ComponentsBiospecimen components
    0 mM added Ca
    0.5 mM added Ca
    1 mM added Ca
    2 mM added Ca
    5 mM added Ca
    50 uM RGDS added
    500 uM aspirin
    Indomethacin
    No aspirin
    No indomethacin
    Biospecimen Aliquots and ComponentsBiospecimen mixing
    Stirred
    Unstirred
    Biospecimen Aliquots and ComponentsBlood and blood products
    Platelet-rich plasma
    Platelets
    Hematology/ auto analyzer SpecificReaction solution
    ADP
    Arachidonic acid
    Collagen
    PAF
    Thrombin